The RNA Analysis /Transcriptomic market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our latest research, the global RNA Analysis /Transcriptomic size is estimated to be USD xx million in 2026 from USD xx million in 2020, with a change XX% between 2020 and 2021. The global RNA Analysis /Transcriptomic market size is expected to grow at a CAGR of xx% for the next five years.
Market segmentation
RNA Analysis /Transcriptomic market is split by Type and by Application. For the period 2016-2026, the growth among segments provide accurate calculations and forecasts for revenue by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Microarrays
Sequencing
Polymerase Chain Reaction
RNA Interference
Market segment by Application, can be divided into
Clinical Diagnostics
Drug Discovery
Toxicogenomics
Comparative Transcriptomics
Market segment by players, this report covers
Thermo Fisher Scientific, Inc.
Bio-Rad Laboratories, Inc.
Merck KGaA
Agilent Technologies, Inc.
F. Hoffmann-La Roche Ltd.
Danaher Corporation
Fluidigm Corporation
Eurofins Scientific
Sequentia Biotech SL
Acobiom
GenXPro GmbH
CD Genomics
Promega Corporation
Cenix BioScience GmbH
Takara Holdings, Inc.
bioMérieux SA
LC Sciences LLC
Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, and Rest of Asia-Pacific)
South America (Brazil, Argentina, Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
1 Market Overview
1.1 Product Overview and Scope of RNA Analysis /Transcriptomic
1.2 Classification of RNA Analysis /Transcriptomic by Type
1.2.1 Overview: Global RNA Analysis /Transcriptomic Market Size by Type: 2020 Versus 2021 Versus 2026
1.2.2 Global RNA Analysis /Transcriptomic Revenue Market Share by Type in 2020
1.2.3 Microarrays
1.2.4 Sequencing
1.2.5 Polymerase Chain Reaction
1.2.6 RNA Interference
1.3 Global RNA Analysis /Transcriptomic Market by Application
1.3.1 Overview: Global RNA Analysis /Transcriptomic Market Size by Application: 2020 Versus 2021 Versus 2026
1.3.2 Clinical Diagnostics
1.3.3 Drug Discovery
1.3.4 Toxicogenomics
1.3.5 Comparative Transcriptomics
1.4 Global RNA Analysis /Transcriptomic Market Size & Forecast
1.5 Global RNA Analysis /Transcriptomic Market Size and Forecast by Region
1.5.1 Global RNA Analysis /Transcriptomic Market Size by Region: 2016 VS 2021 VS 2026
1.5.2 Global RNA Analysis /Transcriptomic Market Size by Region, (2016-2021)
1.5.3 North America RNA Analysis /Transcriptomic Market Size and Prospect (2016-2026)
1.5.4 Europe RNA Analysis /Transcriptomic Market Size and Prospect (2016-2026)
1.5.5 Asia-Pacific RNA Analysis /Transcriptomic Market Size and Prospect (2016-2026)
1.5.6 South America RNA Analysis /Transcriptomic Market Size and Prospect (2016-2026)
1.5.7 Middle East and Africa RNA Analysis /Transcriptomic Market Size and Prospect (2016-2026)
1.6 Market Drivers, Restraints and Trends
1.6.1 RNA Analysis /Transcriptomic Market Drivers
1.6.2 RNA Analysis /Transcriptomic Market Restraints
1.6.3 RNA Analysis /Transcriptomic Trends Analysis
2 Company Profiles
2.1 Thermo Fisher Scientific, Inc.
2.1.1 Thermo Fisher Scientific, Inc. Details
2.1.2 Thermo Fisher Scientific, Inc. Major Business
2.1.3 Thermo Fisher Scientific, Inc. RNA Analysis /Transcriptomic Product and Solutions
2.1.4 Thermo Fisher Scientific, Inc. RNA Analysis /Transcriptomic Revenue, Gross Margin and Market Share (2019-2021)
2.1.5 Thermo Fisher Scientific, Inc. Recent Developments and Future Plans
2.2 Bio-Rad Laboratories, Inc.
2.2.1 Bio-Rad Laboratories, Inc. Details
2.2.2 Bio-Rad Laboratories, Inc. Major Business
2.2.3 Bio-Rad Laboratories, Inc. RNA Analysis /Transcriptomic Product and Solutions
2.2.4 Bio-Rad Laboratories, Inc. RNA Analysis /Transcriptomic Revenue, Gross Margin and Market Share (2019-2021)
2.2.5 Bio-Rad Laboratories, Inc. Recent Developments and Future Plans
2.3 Merck KGaA
2.3.1 Merck KGaA Details
2.3.2 Merck KGaA Major Business
2.3.3 Merck KGaA RNA Analysis /Transcriptomic Product and Solutions
2.3.4 Merck KGaA RNA Analysis /Transcriptomic Revenue, Gross Margin and Market Share (2019-2021)
2.3.5 Merck KGaA Recent Developments and Future Plans
2.4 Agilent Technologies, Inc.
2.4.1 Agilent Technologies, Inc. Details
2.4.2 Agilent Technologies, Inc. Major Business
2.4.3 Agilent Technologies, Inc. RNA Analysis /Transcriptomic Product and Solutions
2.4.4 Agilent Technologies, Inc. RNA Analysis /Transcriptomic Revenue, Gross Margin and Market Share (2019-2021)
2.4.5 Agilent Technologies, Inc. Recent Developments and Future Plans
2.5 F. Hoffmann-La Roche Ltd.
2.5.1 F. Hoffmann-La Roche Ltd. Details
2.5.2 F. Hoffmann-La Roche Ltd. Major Business
2.5.3 F. Hoffmann-La Roche Ltd. RNA Analysis /Transcriptomic Product and Solutions
2.5.4 F. Hoffmann-La Roche Ltd. RNA Analysis /Transcriptomic Revenue, Gross Margin and Market Share (2019-2021)
2.5.5 F. Hoffmann-La Roche Ltd. Recent Developments and Future Plans
2.6 Danaher Corporation
2.6.1 Danaher Corporation Details
2.6.2 Danaher Corporation Major Business
2.6.3 Danaher Corporation RNA Analysis /Transcriptomic Product and Solutions
2.6.4 Danaher Corporation RNA Analysis /Transcriptomic Revenue, Gross Margin and Market Share (2019-2021)
2.6.5 Danaher Corporation Recent Developments and Future Plans
2.7 Fluidigm Corporation
2.7.1 Fluidigm Corporation Details
2.7.2 Fluidigm Corporation Major Business
2.7.3 Fluidigm Corporation RNA Analysis /Transcriptomic Product and Solutions
2.7.4 Fluidigm Corporation RNA Analysis /Transcriptomic Revenue, Gross Margin and Market Share (2019-2021)
2.7.5 Fluidigm Corporation Recent Developments and Future Plans
2.8 Eurofins Scientific
2.8.1 Eurofins Scientific Details
2.8.2 Eurofins Scientific Major Business
2.8.3 Eurofins Scientific RNA Analysis /Transcriptomic Product and Solutions
2.8.4 Eurofins Scientific RNA Analysis /Transcriptomic Revenue, Gross Margin and Market Share (2019-2021)
2.8.5 Eurofins Scientific Recent Developments and Future Plans
2.9 Sequentia Biotech SL
2.9.1 Sequentia Biotech SL Details
2.9.2 Sequentia Biotech SL Major Business
2.9.3 Sequentia Biotech SL RNA Analysis /Transcriptomic Product and Solutions
2.9.4 Sequentia Biotech SL RNA Analysis /Transcriptomic Revenue, Gross Margin and Market Share (2019-2021)
2.9.5 Sequentia Biotech SL Recent Developments and Future Plans
2.10 Acobiom
2.10.1 Acobiom Details
2.10.2 Acobiom Major Business
2.10.3 Acobiom RNA Analysis /Transcriptomic Product and Solutions
2.10.4 Acobiom RNA Analysis /Transcriptomic Revenue, Gross Margin and Market Share (2019-2021)
2.10.5 Acobiom Recent Developments and Future Plans
2.11 GenXPro GmbH
2.11.1 GenXPro GmbH Details
2.11.2 GenXPro GmbH Major Business
2.11.3 GenXPro GmbH RNA Analysis /Transcriptomic Product and Solutions
2.11.4 GenXPro GmbH RNA Analysis /Transcriptomic Revenue, Gross Margin and Market Share (2019-2021)
2.11.5 GenXPro GmbH Recent Developments and Future Plans
2.12 CD Genomics
2.12.1 CD Genomics Details
2.12.2 CD Genomics Major Business
2.12.3 CD Genomics RNA Analysis /Transcriptomic Product and Solutions
2.12.4 CD Genomics RNA Analysis /Transcriptomic Revenue, Gross Margin and Market Share (2019-2021)
2.12.5 CD Genomics Recent Developments and Future Plans
2.13 Promega Corporation
2.13.1 Promega Corporation Details
2.13.2 Promega Corporation Major Business
2.13.3 Promega Corporation RNA Analysis /Transcriptomic Product and Solutions
2.13.4 Promega Corporation RNA Analysis /Transcriptomic Revenue, Gross Margin and Market Share (2019-2021)
2.13.5 Promega Corporation Recent Developments and Future Plans
2.14 Cenix BioScience GmbH
2.14.1 Cenix BioScience GmbH Details
2.14.2 Cenix BioScience GmbH Major Business
2.14.3 Cenix BioScience GmbH RNA Analysis /Transcriptomic Product and Solutions
2.14.4 Cenix BioScience GmbH RNA Analysis /Transcriptomic Revenue, Gross Margin and Market Share (2019-2021)
2.14.5 Cenix BioScience GmbH Recent Developments and Future Plans
2.15 Takara Holdings, Inc.
2.15.1 Takara Holdings, Inc. Details
2.15.2 Takara Holdings, Inc. Major Business
2.15.3 Takara Holdings, Inc. RNA Analysis /Transcriptomic Product and Solutions
2.15.4 Takara Holdings, Inc. RNA Analysis /Transcriptomic Revenue, Gross Margin and Market Share (2019-2021)
2.15.5 Takara Holdings, Inc. Recent Developments and Future Plans
2.16 bioMérieux SA
2.16.1 bioMérieux SA Details
2.16.2 bioMérieux SA Major Business
2.16.3 bioMérieux SA RNA Analysis /Transcriptomic Product and Solutions
2.16.4 bioMérieux SA RNA Analysis /Transcriptomic Revenue, Gross Margin and Market Share (2019-2021)
2.16.5 bioMérieux SA Recent Developments and Future Plans
2.17 LC Sciences LLC
2.17.1 LC Sciences LLC Details
2.17.2 LC Sciences LLC Major Business
2.17.3 LC Sciences LLC RNA Analysis /Transcriptomic Product and Solutions
2.17.4 LC Sciences LLC RNA Analysis /Transcriptomic Revenue, Gross Margin and Market Share (2019-2021)
2.17.5 LC Sciences LLC Recent Developments and Future Plans
3 Market Competition, by Players
3.1 Global RNA Analysis /Transcriptomic Revenue and Share by Players (2019-2021)
3.2 Market Concentration Rate
3.2.1 Top 3 RNA Analysis /Transcriptomic Players Market Share
3.2.2 Top 10 RNA Analysis /Transcriptomic Players Market Share
3.2.3 Market Competition Trend
3.3 RNA Analysis /Transcriptomic Players Head Office, Products and Services Provided
3.4 Mergers & Acquisitions
3.5 New Entrants and Expansion Plans
4 Market Size Segment by Type
4.1 Global RNA Analysis /Transcriptomic Revenue and Market Share by Type (2016-2021)
4.2 Global RNA Analysis /Transcriptomic Market Forecast by Type (2021-2026)
5 Market Size Segment by Application
5.1 Global RNA Analysis /Transcriptomic Revenue Market Share by Application (2016-2021)
5.2 RNA Analysis /Transcriptomic Market Forecast by Application (2021-2026)
6 North America by Country, by Type, and by Application
6.1 North America RNA Analysis /Transcriptomic Revenue by Type (2016-2026)
6.2 North America RNA Analysis /Transcriptomic Revenue by Application (2016-2026)
6.3 North America RNA Analysis /Transcriptomic Market Size by Country
6.3.1 North America RNA Analysis /Transcriptomic Revenue by Country (2016-2026)
6.3.2 United States RNA Analysis /Transcriptomic Market Size and Forecast (2016-2026)
6.3.3 Canada RNA Analysis /Transcriptomic Market Size and Forecast (2016-2026)
6.3.4 Mexico RNA Analysis /Transcriptomic Market Size and Forecast (2016-2026)
7 Europe by Country, by Type, and by Application
7.1 Europe RNA Analysis /Transcriptomic Revenue by Type (2016-2026)
7.2 Europe RNA Analysis /Transcriptomic Revenue by Application (2016-2026)
7.3 Europe RNA Analysis /Transcriptomic Market Size by Country
7.3.1 Europe RNA Analysis /Transcriptomic Revenue by Country (2016-2026)
7.3.2 Germany RNA Analysis /Transcriptomic Market Size and Forecast (2016-2026)
7.3.3 France RNA Analysis /Transcriptomic Market Size and Forecast (2016-2026)
7.3.4 United Kingdom RNA Analysis /Transcriptomic Market Size and Forecast (2016-2026)
7.3.5 Russia RNA Analysis /Transcriptomic Market Size and Forecast (2016-2026)
7.3.6 Italy RNA Analysis /Transcriptomic Market Size and Forecast (2016-2026)
8 Asia-Pacific by Region, by Type, and by Application
8.1 Asia-Pacific RNA Analysis /Transcriptomic Revenue by Type (2016-2026)
8.2 Asia-Pacific RNA Analysis /Transcriptomic Revenue by Application (2016-2026)
8.3 Asia-Pacific RNA Analysis /Transcriptomic Market Size by Region
8.3.1 Asia-Pacific RNA Analysis /Transcriptomic Revenue by Region (2016-2026)
8.3.2 China RNA Analysis /Transcriptomic Market Size and Forecast (2016-2026)
8.3.3 Japan RNA Analysis /Transcriptomic Market Size and Forecast (2016-2026)
8.3.4 South Korea RNA Analysis /Transcriptomic Market Size and Forecast (2016-2026)
8.3.5 India RNA Analysis /Transcriptomic Market Size and Forecast (2016-2026)
8.3.6 Southeast Asia RNA Analysis /Transcriptomic Market Size and Forecast (2016-2026)
8.3.7 Australia RNA Analysis /Transcriptomic Market Size and Forecast (2016-2026)
9 South America by Country, by Type, and by Application
9.1 South America RNA Analysis /Transcriptomic Revenue by Type (2016-2026)
9.2 South America RNA Analysis /Transcriptomic Revenue by Application (2016-2026)
9.3 South America RNA Analysis /Transcriptomic Market Size by Country
9.3.1 South America RNA Analysis /Transcriptomic Revenue by Country (2016-2026)
9.3.2 Brazil RNA Analysis /Transcriptomic Market Size and Forecast (2016-2026)
9.3.3 Argentina RNA Analysis /Transcriptomic Market Size and Forecast (2016-2026)
10 Middle East & Africa by Country, by Type, and by Application
10.1 Middle East & Africa RNA Analysis /Transcriptomic Revenue by Type (2016-2026)
10.2 Middle East & Africa RNA Analysis /Transcriptomic Revenue by Application (2016-2026)
10.3 Middle East & Africa RNA Analysis /Transcriptomic Market Size by Country
10.3.1 Middle East & Africa RNA Analysis /Transcriptomic Revenue by Country (2016-2026)
10.3.2 Turkey RNA Analysis /Transcriptomic Market Size and Forecast (2016-2026)
10.3.3 Saudi Arabia RNA Analysis /Transcriptomic Market Size and Forecast (2016-2026)
10.3.4 UAE RNA Analysis /Transcriptomic Market Size and Forecast (2016-2026)
11 Research Findings and Conclusion
12 Appendix
12.1 Methodology
12.2 Research Process and Data Source
12.3 Disclaimer
List of Tables
Table 1. Global RNA Analysis /Transcriptomic Revenue by Type, (USD Million), 2020 VS 2021 VS 2026
Table 2. Global RNA Analysis /Transcriptomic Revenue by Application, (USD Million), 2020 VS 2021 VS 2026
Table 3. Global Market RNA Analysis /Transcriptomic Revenue (Million USD) Comparison by Region (2016 VS 2021 VS 2026)
Table 4. Global RNA Analysis /Transcriptomic Revenue (USD Million) by Region (2016-2021)
Table 5. Global RNA Analysis /Transcriptomic Revenue Market Share by Region (2021-2026)
Table 6. Thermo Fisher Scientific, Inc. Corporate Information, Head Office, and Major Competitors
Table 7. Thermo Fisher Scientific, Inc. Major Business
Table 8. Thermo Fisher Scientific, Inc. RNA Analysis /Transcriptomic Product and Solutions
Table 9. Thermo Fisher Scientific, Inc. RNA Analysis /Transcriptomic Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 10. Bio-Rad Laboratories, Inc. Corporate Information, Head Office, and Major Competitors
Table 11. Bio-Rad Laboratories, Inc. Major Business
Table 12. Bio-Rad Laboratories, Inc. RNA Analysis /Transcriptomic Product and Solutions
Table 13. Bio-Rad Laboratories, Inc. RNA Analysis /Transcriptomic Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 14. Merck KGaA Corporate Information, Head Office, and Major Competitors
Table 15. Merck KGaA Major Business
Table 16. Merck KGaA RNA Analysis /Transcriptomic Product and Solutions
Table 17. Merck KGaA RNA Analysis /Transcriptomic Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 18. Agilent Technologies, Inc. Corporate Information, Head Office, and Major Competitors
Table 19. Agilent Technologies, Inc. Major Business
Table 20. Agilent Technologies, Inc. RNA Analysis /Transcriptomic Product and Solutions
Table 21. Agilent Technologies, Inc. RNA Analysis /Transcriptomic Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 22. F. Hoffmann-La Roche Ltd. Corporate Information, Head Office, and Major Competitors
Table 23. F. Hoffmann-La Roche Ltd. Major Business
Table 24. F. Hoffmann-La Roche Ltd. RNA Analysis /Transcriptomic Product and Solutions
Table 25. F. Hoffmann-La Roche Ltd. RNA Analysis /Transcriptomic Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 26. Danaher Corporation Corporate Information, Head Office, and Major Competitors
Table 27. Danaher Corporation Major Business
Table 28. Danaher Corporation RNA Analysis /Transcriptomic Product and Solutions
Table 29. Danaher Corporation RNA Analysis /Transcriptomic Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 30. Fluidigm Corporation Corporate Information, Head Office, and Major Competitors
Table 31. Fluidigm Corporation Major Business
Table 32. Fluidigm Corporation RNA Analysis /Transcriptomic Product and Solutions
Table 33. Fluidigm Corporation RNA Analysis /Transcriptomic Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 34. Eurofins Scientific Corporate Information, Head Office, and Major Competitors
Table 35. Eurofins Scientific Major Business
Table 36. Eurofins Scientific RNA Analysis /Transcriptomic Product and Solutions
Table 37. Eurofins Scientific RNA Analysis /Transcriptomic Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 38. Sequentia Biotech SL Corporate Information, Head Office, and Major Competitors
Table 39. Sequentia Biotech SL Major Business
Table 40. Sequentia Biotech SL RNA Analysis /Transcriptomic Product and Solutions
Table 41. Sequentia Biotech SL RNA Analysis /Transcriptomic Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 42. Acobiom Corporate Information, Head Office, and Major Competitors
Table 43. Acobiom Major Business
Table 44. Acobiom RNA Analysis /Transcriptomic Product and Solutions
Table 45. Acobiom RNA Analysis /Transcriptomic Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 46. GenXPro GmbH Corporate Information, Head Office, and Major Competitors
Table 47. GenXPro GmbH Major Business
Table 48. GenXPro GmbH RNA Analysis /Transcriptomic Product and Solutions
Table 49. GenXPro GmbH RNA Analysis /Transcriptomic Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 50. CD Genomics Corporate Information, Head Office, and Major Competitors
Table 51. CD Genomics Major Business
Table 52. CD Genomics RNA Analysis /Transcriptomic Product and Solutions
Table 53. CD Genomics RNA Analysis /Transcriptomic Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 54. Promega Corporation Corporate Information, Head Office, and Major Competitors
Table 55. Promega Corporation Major Business
Table 56. Promega Corporation RNA Analysis /Transcriptomic Product and Solutions
Table 57. Promega Corporation RNA Analysis /Transcriptomic Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 58. Cenix BioScience GmbH Corporate Information, Head Office, and Major Competitors
Table 59. Cenix BioScience GmbH Major Business
Table 60. Cenix BioScience GmbH RNA Analysis /Transcriptomic Product and Solutions
Table 61. Cenix BioScience GmbH RNA Analysis /Transcriptomic Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 62. Takara Holdings, Inc. Corporate Information, Head Office, and Major Competitors
Table 63. Takara Holdings, Inc. Major Business
Table 64. Takara Holdings, Inc. RNA Analysis /Transcriptomic Product and Solutions
Table 65. Takara Holdings, Inc. RNA Analysis /Transcriptomic Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 66. bioMérieux SA Corporate Information, Head Office, and Major Competitors
Table 67. bioMérieux SA Major Business
Table 68. bioMérieux SA RNA Analysis /Transcriptomic Product and Solutions
Table 69. bioMérieux SA RNA Analysis /Transcriptomic Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 70. LC Sciences LLC Corporate Information, Head Office, and Major Competitors
Table 71. LC Sciences LLC Major Business
Table 72. LC Sciences LLC RNA Analysis /Transcriptomic Product and Solutions
Table 73. LC Sciences LLC RNA Analysis /Transcriptomic Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 74. Global RNA Analysis /Transcriptomic Revenue (USD Million) by Players (2019-2021)
Table 75. Global RNA Analysis /Transcriptomic Revenue Share by Players (2019-2021)
Table 76. Breakdown of RNA Analysis /Transcriptomic by Company Type (Tier 1, Tier 2 and Tier 3)
Table 77. RNA Analysis /Transcriptomic Players Head Office, Products and Services Provided
Table 78. RNA Analysis /Transcriptomic Mergers & Acquisitions in the Past Five Years
Table 79. RNA Analysis /Transcriptomic New Entrants and Expansion Plans
Table 80. Global RNA Analysis /Transcriptomic Revenue (USD Million) by Type (2016-2021)
Table 81. Global RNA Analysis /Transcriptomic Revenue Share by Type (2016-2021)
Table 82. Global RNA Analysis /Transcriptomic Revenue Forecast by Type (2021-2026)
Table 83. Global RNA Analysis /Transcriptomic Revenue by Application (2016-2021)
Table 84. Global RNA Analysis /Transcriptomic Revenue Forecast by Application (2021-2026)
Table 85. North America RNA Analysis /Transcriptomic Revenue by Type (2016-2021) & (USD Million)
Table 86. North America RNA Analysis /Transcriptomic Revenue by Type (2021-2026) & (USD Million)
Table 87. North America RNA Analysis /Transcriptomic Revenue by Application (2016-2021) & (USD Million)
Table 88. North America RNA Analysis /Transcriptomic Revenue by Application (2021-2026) & (USD Million)
Table 89. North America RNA Analysis /Transcriptomic Revenue by Country (2016-2021) & (USD Million)
Table 90. North America RNA Analysis /Transcriptomic Revenue by Country (2021-2026) & (USD Million)
Table 91. Europe RNA Analysis /Transcriptomic Revenue by Type (2016-2021) & (USD Million)
Table 92. Europe RNA Analysis /Transcriptomic Revenue by Type (2021-2026) & (USD Million)
Table 93. Europe RNA Analysis /Transcriptomic Revenue by Application (2016-2021) & (USD Million)
Table 94. Europe RNA Analysis /Transcriptomic Revenue by Application (2021-2026) & (USD Million)
Table 95. Europe RNA Analysis /Transcriptomic Revenue by Country (2016-2021) & (USD Million)
Table 96. Europe RNA Analysis /Transcriptomic Revenue by Country (2021-2026) & (USD Million)
Table 97. Asia-Pacific RNA Analysis /Transcriptomic Revenue by Type (2016-2021) & (USD Million)
Table 98. Asia-Pacific RNA Analysis /Transcriptomic Revenue by Type (2021-2026) & (USD Million)
Table 99. Asia-Pacific RNA Analysis /Transcriptomic Revenue by Application (2016-2021) & (USD Million)
Table 100. Asia-Pacific RNA Analysis /Transcriptomic Revenue by Application (2021-2026) & (USD Million)
Table 101. Asia-Pacific RNA Analysis /Transcriptomic Revenue by Region (2016-2021) & (USD Million)
Table 102. Asia-Pacific RNA Analysis /Transcriptomic Revenue by Region (2021-2026) & (USD Million)
Table 103. South America RNA Analysis /Transcriptomic Revenue by Type (2016-2021) & (USD Million)
Table 104. South America RNA Analysis /Transcriptomic Revenue by Type (2021-2026) & (USD Million)
Table 105. South America RNA Analysis /Transcriptomic Revenue by Application (2016-2021) & (USD Million)
Table 106. South America RNA Analysis /Transcriptomic Revenue by Application (2021-2026) & (USD Million)
Table 107. South America RNA Analysis /Transcriptomic Revenue by Country (2016-2021) & (USD Million)
Table 108. South America RNA Analysis /Transcriptomic Revenue by Country (2021-2026) & (USD Million)
Table 109. Middle East & Africa RNA Analysis /Transcriptomic Revenue by Type (2016-2021) & (USD Million)
Table 110. Middle East & Africa RNA Analysis /Transcriptomic Revenue by Type (2021-2026) & (USD Million)
Table 111. Middle East & Africa RNA Analysis /Transcriptomic Revenue by Application (2016-2021) & (USD Million)
Table 112. Middle East & Africa RNA Analysis /Transcriptomic Revenue by Application (2021-2026) & (USD Million)
Table 113. Middle East & Africa RNA Analysis /Transcriptomic Revenue by Country (2016-2021) & (USD Million)
Table 114. Middle East & Africa RNA Analysis /Transcriptomic Revenue by Country (2021-2026) & (USD Million)
List of Figures
Figure 1. RNA Analysis /Transcriptomic Picture
Figure 2. Global RNA Analysis /Transcriptomic Revenue Market Share by Type in 2020
Figure 3. Microarrays
Figure 4. Sequencing
Figure 5. Polymerase Chain Reaction
Figure 6. RNA Interference
Figure 7. RNA Analysis /Transcriptomic Revenue Market Share by Application in 2020
Figure 8. Clinical Diagnostics Picture
Figure 9. Drug Discovery Picture
Figure 10. Toxicogenomics Picture
Figure 11. Comparative Transcriptomics Picture
Figure 12. Global RNA Analysis /Transcriptomic Revenue, (USD Million): 2020 VS 2021 VS 2026
Figure 13. Global RNA Analysis /Transcriptomic Revenue and Forecast (2016-2026) & (USD Million)
Figure 14. Global RNA Analysis /Transcriptomic Revenue Market Share by Region (2016-2026)
Figure 15. Global RNA Analysis /Transcriptomic Revenue Market Share by Region in 2020
Figure 16. North America RNA Analysis /Transcriptomic Revenue (USD Million) and Growth Rate (2016-2026)
Figure 17. Europe RNA Analysis /Transcriptomic Revenue (USD Million) and Growth Rate (2016-2026)
Figure 18. Asia-Pacific RNA Analysis /Transcriptomic Revenue (USD Million) and Growth Rate (2016-2026)
Figure 19. South America RNA Analysis /Transcriptomic Revenue (USD Million) and Growth Rate (2016-2026)
Figure 20. Middle East and Africa RNA Analysis /Transcriptomic Revenue (USD Million) and Growth Rate (2016-2026)
Figure 21. RNA Analysis /Transcriptomic Market Drivers
Figure 22. RNA Analysis /Transcriptomic Market Restraints
Figure 23. RNA Analysis /Transcriptomic Market Trends
Figure 24. Thermo Fisher Scientific, Inc. Recent Developments and Future Plans
Figure 25. Bio-Rad Laboratories, Inc. Recent Developments and Future Plans
Figure 26. Merck KGaA Recent Developments and Future Plans
Figure 27. Agilent Technologies, Inc. Recent Developments and Future Plans
Figure 28. F. Hoffmann-La Roche Ltd. Recent Developments and Future Plans
Figure 29. Danaher Corporation Recent Developments and Future Plans
Figure 30. Fluidigm Corporation Recent Developments and Future Plans
Figure 31. Eurofins Scientific Recent Developments and Future Plans
Figure 32. Sequentia Biotech SL Recent Developments and Future Plans
Figure 33. Acobiom Recent Developments and Future Plans
Figure 34. GenXPro GmbH Recent Developments and Future Plans
Figure 35. CD Genomics Recent Developments and Future Plans
Figure 36. Promega Corporation Recent Developments and Future Plans
Figure 37. Cenix BioScience GmbH Recent Developments and Future Plans
Figure 38. Takara Holdings, Inc. Recent Developments and Future Plans
Figure 39. bioMérieux SA Recent Developments and Future Plans
Figure 40. LC Sciences LLC Recent Developments and Future Plans
Figure 41. Global RNA Analysis /Transcriptomic Revenue Share by Players in 2020
Figure 42. RNA Analysis /Transcriptomic Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
Figure 43. Global Top 3 Players RNA Analysis /Transcriptomic Revenue Market Share in 2020
Figure 44. Global Top 10 Players RNA Analysis /Transcriptomic Revenue Market Share in 2020
Figure 45. Key Players Market Share Trend (Top 3 Market Share: 2019 VS 2020 VS 2021)
Figure 46. Global RNA Analysis /Transcriptomic Revenue Share by Type in 2020
Figure 47. Global RNA Analysis /Transcriptomic Market Share Forecast by Type (2021-2026)
Figure 48. Global RNA Analysis /Transcriptomic Revenue Share by Application in 2020
Figure 49. Global RNA Analysis /Transcriptomic Market Share Forecast by Application (2021-2026)
Figure 50. North America RNA Analysis /Transcriptomic Sales Market Share by Type (2016-2026)
Figure 51. North America RNA Analysis /Transcriptomic Sales Market Share by Application (2016-2026)
Figure 52. North America RNA Analysis /Transcriptomic Revenue Market Share by Country (2016-2026)
Figure 53. United States RNA Analysis /Transcriptomic Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 54. Canada RNA Analysis /Transcriptomic Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 55. Mexico RNA Analysis /Transcriptomic Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 56. Europe RNA Analysis /Transcriptomic Sales Market Share by Type (2016-2026)
Figure 57. Europe RNA Analysis /Transcriptomic Sales Market Share by Application (2016-2026)
Figure 58. Europe RNA Analysis /Transcriptomic Revenue Market Share by Country (2016-2026)
Figure 59. Germany RNA Analysis /Transcriptomic Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 60. France RNA Analysis /Transcriptomic Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 61. United Kingdom RNA Analysis /Transcriptomic Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 62. Russia RNA Analysis /Transcriptomic Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 63. Italy RNA Analysis /Transcriptomic Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 64. Asia-Pacific RNA Analysis /Transcriptomic Sales Market Share by Type (2016-2026)
Figure 65. Asia-Pacific RNA Analysis /Transcriptomic Sales Market Share by Application (2016-2026)
Figure 66. Asia-Pacific RNA Analysis /Transcriptomic Revenue Market Share by Region (2016-2026)
Figure 67. China RNA Analysis /Transcriptomic Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 68. Japan RNA Analysis /Transcriptomic Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 69. South Korea RNA Analysis /Transcriptomic Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 70. India RNA Analysis /Transcriptomic Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 71. Southeast Asia RNA Analysis /Transcriptomic Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 72. Australia RNA Analysis /Transcriptomic Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 73. South America RNA Analysis /Transcriptomic Sales Market Share by Type (2016-2026)
Figure 74. South America RNA Analysis /Transcriptomic Sales Market Share by Application (2016-2026)
Figure 75. South America RNA Analysis /Transcriptomic Revenue Market Share by Country (2016-2026)
Figure 76. Brazil RNA Analysis /Transcriptomic Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 77. Argentina RNA Analysis /Transcriptomic Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 78. Middle East and Africa RNA Analysis /Transcriptomic Sales Market Share by Type (2016-2026)
Figure 79. Middle East and Africa RNA Analysis /Transcriptomic Sales Market Share by Application (2016-2026)
Figure 80. Middle East and Africa RNA Analysis /Transcriptomic Revenue Market Share by Country (2016-2026)
Figure 81. Turkey RNA Analysis /Transcriptomic Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 82. Saudi Arabia RNA Analysis /Transcriptomic Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 83. UAE RNA Analysis /Transcriptomic Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 84. Methodology
Figure 85. Research Process and Data Source